CVR Medical (OTCMKTS:CRRVF) versus NEXGEL (NASDAQ:NXGL) Financial Comparison

CVR Medical (OTCMKTS:CRRVFGet Rating) and NEXGEL (NASDAQ:NXGLGet Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation.

Analyst Ratings

This is a breakdown of recent ratings and target prices for CVR Medical and NEXGEL, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVR Medical 0 0 0 0 N/A
NEXGEL 0 0 0 0 N/A

Volatility & Risk

CVR Medical has a beta of 21.88, indicating that its stock price is 2,088% more volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Profitability

This table compares CVR Medical and NEXGEL’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CVR Medical N/A N/A -4,885.94%
NEXGEL -163.84% -45.75% -32.13%

Valuation and Earnings

This table compares CVR Medical and NEXGEL’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CVR Medical N/A N/A -$1.82 million ($0.02) N/A
NEXGEL $2.05 million 7.14 -$4.75 million ($0.67) -3.90

CVR Medical has higher earnings, but lower revenue than NEXGEL. NEXGEL is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

1.9% of NEXGEL shares are held by institutional investors. 25.2% of NEXGEL shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

CVR Medical beats NEXGEL on 5 of the 9 factors compared between the two stocks.

About CVR Medical

(Get Rating)

CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its Carotid Stenotic Scan (CSS). Its CSS device is a diagnostic tool that encompasses subsonic, infrasonic and low frequency sound wave analysis technology, which is designed to detect and measure carotid arterial stenosis. The company was founded on December 10, 1980 and is headquartered in North Vancouver, Canada.

About NEXGEL

(Get Rating)

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

Receive News & Ratings for CVR Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVR Medical and related companies with MarketBeat.com's FREE daily email newsletter.